Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

SELL
$36.71 - $44.15 $3,891 - $4,679
-106 Reduced 14.76%
612 $25,000
Q1 2023

May 09, 2023

SELL
$36.81 - $48.12 $18,515 - $24,204
-503 Reduced 41.2%
718 $29,000
Q4 2022

Feb 13, 2023

SELL
$35.68 - $44.71 $1,676 - $2,101
-47 Reduced 3.71%
1,221 $50,000
Q3 2022

Oct 27, 2022

SELL
$42.51 - $54.02 $67,463 - $85,729
-1,587 Reduced 55.59%
1,268 $56,000
Q2 2022

Aug 01, 2022

SELL
$46.84 - $59.75 $47,214 - $60,228
-1,008 Reduced 26.09%
2,855 $141,000
Q1 2022

May 11, 2022

SELL
$48.09 - $57.79 $15,965 - $19,186
-332 Reduced 7.91%
3,863 $220,000
Q4 2021

Feb 11, 2022

SELL
$47.19 - $62.68 $18,026 - $23,943
-382 Reduced 8.35%
4,195 $220,000
Q3 2021

Nov 10, 2021

SELL
$56.91 - $67.81 $76,031 - $90,594
-1,336 Reduced 22.59%
4,577 $273,000
Q2 2021

Aug 05, 2021

SELL
$64.02 - $71.72 $101,471 - $113,676
-1,585 Reduced 21.14%
5,913 $401,000
Q1 2021

Apr 28, 2021

BUY
$53.26 - $68.08 $36,376 - $46,498
683 Added 10.02%
7,498 $492,000
Q4 2020

Feb 04, 2021

SELL
$43.41 - $56.51 $29,084 - $37,861
-670 Reduced 8.95%
6,815 $384,000
Q3 2020

Nov 10, 2020

SELL
$47.43 - $60.75 $65,263 - $83,592
-1,376 Reduced 15.53%
7,485 $363,000
Q2 2020

Aug 07, 2020

BUY
$43.51 - $66.59 $25,279 - $38,688
581 Added 7.02%
8,861 $494,000
Q1 2020

May 13, 2020

SELL
$32.82 - $81.13 $25,566 - $63,200
-779 Reduced 8.6%
8,280 $419,000
Q4 2019

Feb 04, 2020

SELL
$60.96 - $77.7 $46,451 - $59,207
-762 Reduced 7.76%
9,059 $699,000
Q3 2019

Nov 08, 2019

SELL
$55.78 - $68.08 $110,109 - $134,389
-1,974 Reduced 16.74%
9,821 $623,000
Q2 2019

Aug 13, 2019

SELL
$53.69 - $65.47 $101,205 - $123,410
-1,885 Reduced 13.78%
11,795 $691,000
Q1 2019

May 08, 2019

SELL
$44.53 - $58.9 $52,857 - $69,914
-1,187 Reduced 7.98%
13,680 $776,000
Q4 2018

Feb 13, 2019

BUY
$47.64 - $71.26 $305,753 - $457,346
6,418 Added 75.96%
14,867 $736,000
Q3 2018

Nov 01, 2018

BUY
$52.03 - $71.41 $140,116 - $192,307
2,693 Added 46.79%
8,449 $601,000
Q2 2018

Aug 08, 2018

BUY
$48.15 - $56.68 $228,808 - $269,343
4,752 Added 473.31%
5,756 $300,000
Q1 2018

May 08, 2018

SELL
$46.03 - $61.28 $11,645 - $15,503
-253 Reduced 20.13%
1,004 $52,000
Q4 2017

Feb 02, 2018

BUY
$50.58 - $60.79 $14,061 - $16,899
278 Added 28.4%
1,257 $73,000
Q3 2017

Nov 13, 2017

BUY
$53.54 - $68.0 $52,415 - $66,572
979
979 $54,000

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.